Sutro Biopharma Inc
NASDAQ:STRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
M
|
Microsoft Corp
XMUN:MSF
|
US |
|
V
|
Vinci SA
F:SQUA
|
FR |
|
Schneider Electric SE
PAR:SU
|
FR |
Intrinsic Value
Is STRO undervalued or overvalued?
See the intrinsic value estimate for
Sutro Biopharma Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Sutro Biopharma Does
Sutro Biopharma is a biotechnology company that designs cancer drugs, especially antibody-drug conjugates and other targeted biologic medicines. Its main job is to build drug candidates that can carry a cancer-killing payload directly to tumor cells while trying to spare healthy tissue. The company sells the drugs themselves only if they are approved in the future, so today it is mainly focused on research and development.
- Headquarters
- United States of America US
- Employees
- 137
- IPO date
- Sep 27, 2018
Revenue & Expenses Breakdown
Sutro Biopharma Inc
Earnings Waterfall
Sutro Biopharma Inc
The intrinsic value for
Sutro Biopharma Inc (STRO) under the Base Case is hidden USD.
Compared with the current market price of 9.11 USD, the stock appears hidden.